Pre-earnings options volume in Assertio Therapeutics is 1.8x normal with calls leading puts 13:2. Implied volatility suggests the market is anticipating a move near 29.1%, or 28c, after results are released. Median move over the past eight quarters is 10.4%.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.